Skip to main content

Table 3 Predictors of two visit-defined lupus retention in care (n = 372, multivariable analysis included 372 of 397 SLE patients with complete data)

From: Investigating lupus retention in care to inform interventions for disparities reduction: an observational cohort study

 Unadjusted OR (95% CI)Adjusted OR (95% Cl)
Age
 18–29RefRef
 30–400.95 (0.47, 1.93)0.81 (0.36, 1.81)
 40–600.65 (0.34, 1.24)0.65 (0.31, 1.36)
 60–800.62 (0.29, 1.30)0.71 (0.30, 1.68)
 80+0.75 (0.11, 4.90)1.15 (0.11, 12.38)
Female0.73 (0.35, 1.50)0.50 (0.22, 1.12)
Race
 WhiteRefRef
 Black1.24 (0.81, 1.89)1.56 (0.81, 3.03)
 Other0.71 (0.29, 1.78)0.98 (0.29, 3.33)
Ethnicity (Hispanic)0.52 (0.20, 1.34)0.63 (0.18, 2.28)
RUCA
 UrbanRefRef
 Suburban1.03 (0.51, 2.08)1.19 (0.54, 2.65)
 Large town1.31 (0.44, 3.91)1.12 (0.33, 3.88)
 Small town0.46 (0.17, 1.23)0.41 (0.14, 1.23)
 Ever Smoking0.63 (0.42, 0.95)0.63 (0.40, 0.99)
Payer
 CommercialRef 
 Medicaid0.72 (0.41, 1.25) 
 Medicare1.25 (0.79, 1.98) 
Neighborhood disadvantage by ADI
 1st (least disadvantage)RefRef
 2nd quartile1.05 (0.58, 1.88)1.02 (0.55 (1.92)
 3rd quartile1.26 (0.69, 2.29)1.01 (0.52, 2.00)
 4th (most disadvantage)0.74 (0.41, 1.32)0.41 (0.18, 0.93)
Number of ACR criteria1.13 (1.01, 1.27)1.10 (0.95, 1.27)
Lupus nephritis1.52 (0.99, 2.32)1.35 (0.78, 2.36)
\